[Glaucoma].
D000086:Acetazolamide / Q000627:therapeutic use; D000792:Angiography; D001082:Aqueous Humor; D002386:Cataract / Q000150:complications; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D002908:Chronic Disease; D003907:Dexamethasone / Q000627:therapeutic use; D005094:Exophthalmos / Q000150:complications; D005260:Female; D005456:Fluorescent Dyes; D005901:Glaucoma / Q000150:complications / Q000188:drug therapy / Q000235:genetics / Q000601:surgery; D005938:Glucocorticoids / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006470:Hemorrhage / Q000150:complications; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D009184:Mydriatics / Q000627:therapeutic use; D010656:Phenylephrine / Q000627:therapeutic use; D012171:Retinal Vessels; D013565:Sympatholytics / Q000627:therapeutic use; D013927:Thrombosis / Q000150:complications; D014065:Tonometry, Ocular; D014794:Visual Fields
D002800:Cholinesterase Inhibitors; D005456:Fluorescent Dyes; D005938:Glucocorticoids; D009184:Mydriatics; D013565:Sympatholytics; D010656:Phenylephrine; D003907:Dexamethasone; D000086:Acetazolamide; D006145:Guanethidine
Glaucome.